LSBio (LifeSpan)

Monoclonal Mouse anti‑Human KRAS Antibody (clone 2C1)

#LS-C175665 · western blot · $459

13
Citing papers
437
Combined citations
Supplier page Find this product

Research areas

Protein Degradation and Inhibitors4Ubiquitin and proteasome pathways4Protein Kinase Regulation and GTPase Signaling3Colorectal Cancer Treatments and Studies3Melanoma and MAPK Pathways2Peptidase Inhibition and Analysis2Cellular transport and secretion2Ferroptosis and cancer prognosis1

Papers citing this product

1
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
Nature Communications·2022·110 cit.·DOI
2
Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
Nature Communications·2017·106 cit.·DOI
3
Small molecule splicing modifiers with systemic HTT-lowering activity
Nature Communications·2021·85 cit.·DOI
4
Confounding Factors in Targeted Degradation of Short-Lived Proteins
ACS Chemical Biology·2024·45 cit.·DOI
5
Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors
Journal of Clinical Investigation·2024·24 cit.·DOI
6
Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recycling
Communications Biology·2021·18 cit.·DOI
7
Mutant-selective Degradation by BRAF-targeting PROTACs
bioRxiv (Cold Spring Harbor Laboratory)·2020·14 cit.·DOI
8
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations
Cancer Discovery·2025·10 cit.·DOI
9
Modulation of Fibroblast Phenotype by Colorectal Cancer Cell-Secreted Factors Is Mostly Independent of Oncogenic KRAS
Cells·2022·10 cit.·DOI
10
LYMTACs:chimeric small molecules repurpose lysosomal membrane proteins for target protein relocalization and degradation
Nature Communications·2025·9 cit.·DOI

Also available from other vendors

This target has 755 citing papers across all vendors combined

VendorProductEvidencePricePapers
Santa Cruz BiotechnologyKRAS Antibody (3B10-2F2)74—1
Santa Cruz BiotechnologyKRAS Antibody (B-12)74—200
Miltenyi BiotecMHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, Vio66778—200
Miltenyi BiotecMHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, Vio66778—5
Miltenyi BiotecMHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, PE78—200
Miltenyi BiotecMHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, PE78—1
MedChemExpressKRAS Antibody (YA6861)74—200
NovusKRAS Antibody (OTI2C1) [DyLight 405]74—200
NovusKRAS Antibody (OTI2C1) [DyLight 350]74—200

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.